Structure |
Chemical Name |
CAS |
MF |
![D-Glucitol, 1,5-anhydro-1-C-[4-Methyl-3-[(5-phenyl-2-thienyl)Methyl]phenyl]-, (1S)-](/CAS/20180906/GIF/842133-16-8.gif) |
D-Glucitol, 1,5-anhydro-1-C-[4-Methyl-3-[(5-phenyl-2-thienyl)Methyl]phenyl]-, (1S)- |
842133-16-8 |
C24H26O5S |
![(alphaE)-alpha-[(3,4-Dihydroxy-5-nitrophenyl)methylene]-beta-oxo-1-piperidinepropanenitrile](/CAS/20150408/GIF/1150310-15-8.gif) |
(alphaE)-alpha-[(3,4-Dihydroxy-5-nitrophenyl)methylene]-beta-oxo-1-piperidinepropanenitrile |
1150310-15-8 |
C15H15N3O5 |
![(E)-N,N-ジエチル-2-シアノ-3-(3-エトキシ-4-ヒドロキシ-5-ニトロフェニル)アクリルアミド](/CAS/20150408/GIF/857629-79-9.gif) |
(E)-N,N-ジエチル-2-シアノ-3-(3-エトキシ-4-ヒドロキシ-5-ニトロフェニル)アクリルアミド |
857629-79-9 |
C16H19N3O5 |
![(R,E)-ethyl 5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)aMino)-2-Methylpent-2-enoate](/CAS/20150408/GIF/149709-59-1.gif) |
(R,E)-ethyl 5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)aMino)-2-Methylpent-2-enoate |
149709-59-1 |
C25H31NO4 |
![1-(3-アミノプロピル)-4-(2-メトキシフェニル)ピペラジン](/CAS/20150408/GIF/20529-23-1.gif) |
1-(3-アミノプロピル)-4-(2-メトキシフェニル)ピペラジン |
20529-23-1 |
C14H23N3O |
![(R)-3-((S)-5-(4-fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one](/CAS/20150408/GIF/404874-94-8.gif) |
(R)-3-((S)-5-(4-fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one |
404874-94-8 |
C20H20FNO4 |
![(S)-3-((S)-5-hydroxy-5-phenylpentanoyl)-4-phenyloxazolidin-2-one](/CAS/20150408/GIF/CB02735623.gif) |
(S)-3-((S)-5-hydroxy-5-phenylpentanoyl)-4-phenyloxazolidin-2-one |
|
C20H21NO4 |
![Posaconazole iMpurity 4](/CAS/20200611/GIF/2125944-53-6.gif) |
Posaconazole iMpurity 4 |
2125944-53-6 |
C30H35N5O3 |
![Everolimus Ring-Opening Impurity](/CAS/20180808/GIF/1708118-13-1.gif) |
Everolimus Ring-Opening Impurity |
1708118-13-1 |
C53H83NO14 |
![Topiroxostat Impurity 6](/CAS/20200611/GIF/2044704-63-2.gif) |
Topiroxostat Impurity 6 |
2044704-63-2 |
C7H8N4O2 |
![Dienogest Impurity I](/CAS/20211123/GIF/65928-65-6.gif) |
Dienogest Impurity I |
65928-65-6 |
C20H27NO2 |
![Febuxostat Impurity 8](/CAS/20180808/GIF/144060-62-8.gif) |
Febuxostat Impurity 8 |
144060-62-8 |
C16H17NO4S |
![Lornoxicam Impurity 9](/CAS/20200611/GIF/70374-36-6.gif) |
Lornoxicam Impurity 9 |
70374-36-6 |
C6H6ClNO4S2 |
![Ticagrelor Related Compound 3](/CAS/20200611/GIF/88756-83-6.gif) |
Ticagrelor Related Compound 3 |
88756-83-6 |
C8H15NO3 |
![Tadalafil EP Impurity](/CAS/20180808/GIF/479545-76-1.gif) |
Tadalafil EP Impurity |
479545-76-1 |
C21H16N2O5 |
![Vonoprazan Impurity C](/) |
Vonoprazan Impurity C |
|
|
![(5RS)-5-Ethyl-2,6-diimino-5-phenyl-1,2,5,6-tetrahydropyrimidin-4(3H)-one](/CAS/20180629/GIF/69125-70-8.gif) |
(5RS)-5-Ethyl-2,6-diimino-5-phenyl-1,2,5,6-tetrahydropyrimidin-4(3H)-one |
69125-70-8 |
C12H14N4O |
![(2S,4R)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid](/CAS/20180629/GIF/1012341-54-6.gif) |
(2S,4R)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid |
1012341-54-6 |
C23H29NO4 |
![3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)benzamide](/CAS/20180629/GIF/917391-28-7.gif) |
3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)benzamide |
917391-28-7 |
C12H10F3N3O |
![Cycloocta[b]pyridine, 2-(4-ethyl-1-piperazinyl)-5,6,7,8,9,10-hexahydro-4-phenyl-](/CAS/20180629/GIF/132810-75-4.gif) |
Cycloocta[b]pyridine, 2-(4-ethyl-1-piperazinyl)-5,6,7,8,9,10-hexahydro-4-phenyl- |
132810-75-4 |
C23H31N3 |
![(R)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)propan-1-one](/CAS/20180629/GIF/1839099-22-7.gif) |
(R)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)propan-1-one |
1839099-22-7 |
C25H26N6O2 |
![Linagliptin Impurity L](/) |
Linagliptin Impurity L |
|
|
![Sunitinib Impurity 4](/) |
Sunitinib Impurity 4 |
|
|
![Tafluprost Impurity 11](/) |
Tafluprost Impurity 11 |
|
|
![Tazobactam Impurity 4](/) |
Tazobactam Impurity 4 |
|
|
![Ticagrelor Impurity 103](/) |
Ticagrelor Impurity 103 |
|
|
![Ticagrelor Impurity 94](/) |
Ticagrelor Impurity 94 |
|
|
![Tofacitinib Impurity 119](/) |
Tofacitinib Impurity 119 |
|
|
![Trelagliptin Impurity 26](/) |
Trelagliptin Impurity 26 |
|
|
![Trelagliptin Impurity 31](/) |
Trelagliptin Impurity 31 |
|
|
![Caspofungin impurity E](/) |
Caspofungin impurity E |
|
|
![Erythromycin Impurity C](/) |
Erythromycin Impurity C |
|
|
![Itraconazole iMpurity 4](/) |
Itraconazole iMpurity 4 |
|
|
![Ozagrel Impurity 2](/) |
Ozagrel Impurity 2 |
|
|
![Olaparib Impurity 22](/) |
Olaparib Impurity 22 |
|
|
![Irbesartan Impurity 14](/CAS/20200119/GIF/CB04918833.gif) |
Irbesartan Impurity 14 |
133690-91-2 |
C25H28N6O |
![Febuxostat Impurity 25](/CAS/20211123/GIF/1643131-89-8.gif) |
Febuxostat Impurity 25 |
1643131-89-8 |
C17H20N2O4S |
![Pregabalin Impurity 3](/CAS/20211123/GIF/1928754-83-9.gif) |
Pregabalin Impurity 3 |
1928754-83-9 |
C12H22O3 |
![Bosutinib Impurity 6](/) |
Bosutinib Impurity 6 |
|
|
![Propofol IMpurity E](/) |
Propofol IMpurity E |
|
|
![Solifenacin Related CoMpound 5](/) |
Solifenacin Related CoMpound 5 |
|
|
![TelMisartan BroMo Ethyl Ester](/CAS/20180808/GIF/133085-87-7.gif) |
TelMisartan BroMo Ethyl Ester |
133085-87-7 |
C16H15BrO2 |
![Tolterodine Lactol IMpurity](/CAS/20180808/GIF/209747-04-6.gif) |
Tolterodine Lactol IMpurity |
209747-04-6 |
C16H16O2 |
![Valsartan N1-Trityl IMpurity](/) |
Valsartan N1-Trityl IMpurity |
|
|
![(3-Carbamoylallyl)trimethylammonium](/CAS/20150408/GIF/857162-57-3.gif) |
(3-Carbamoylallyl)trimethylammonium |
857162-57-3 |
C7H15N2O+ |
![N-(3-クロロ-4-ヒドロキシフェニル)アセトアミド](/CAS/GIF/3964-54-3.gif) |
N-(3-クロロ-4-ヒドロキシフェニル)アセトアミド |
3964-54-3 |
C8H8ClNO2 |
![ent-14S-3-Methoxy-17-MethylMorphinan](/CAS/20150408/GIF/1453167-99-1.gif) |
ent-14S-3-Methoxy-17-MethylMorphinan |
1453167-99-1 |
C18H25NO |
![PD 224378](/CAS/GIF/501665-88-9.gif) |
PD 224378 |
501665-88-9 |
C20H35NO11 |
![(rac,syn)-4-Deschloro-sertraline](/CAS/GIF/871838-58-3.gif) |
(rac,syn)-4-Deschloro-sertraline |
871838-58-3 |
C17H18ClN |
![1-[2-(DiMethylaMino)-1-phenylethyl]cyclohexanol](/CAS/20150408/GIF/93413-86-6.gif) |
1-[2-(DiMethylaMino)-1-phenylethyl]cyclohexanol |
93413-86-6 |
C16H25NO |
![1-[4-(2-Methoxyethenyl)phenoxy]-3-[(1-Methylethyl)aMino]-2-propanol](/CAS/20150408/GIF/82961-02-2.gif) |
1-[4-(2-Methoxyethenyl)phenoxy]-3-[(1-Methylethyl)aMino]-2-propanol |
82961-02-2 |
C15H23NO3 |
![11-Desethyl Irinotecan](/CAS/GIF/103816-16-6.gif) |
11-Desethyl Irinotecan |
103816-16-6 |
C31H34N4O6 |
![7-[[[(CyanoMethyl)thio]acetyl]aMino]-7-Methoxy Cephalosporanic Acid](/CAS/GIF/56796-16-8.gif) |
7-[[[(CyanoMethyl)thio]acetyl]aMino]-7-Methoxy Cephalosporanic Acid |
56796-16-8 |
C15H17N3O7S2 |
![7S-Cefdinir](/CAS/20180808/GIF/178601-89-3.gif) |
7S-Cefdinir |
178601-89-3 |
C14H13N5O5S2 |
![Ticagrelor Impurity 49](/) |
Ticagrelor Impurity 49 |
2376278-80-5 |
|
![Edoxaban Impurity 14](/) |
Edoxaban Impurity 14 |
|
|
![Carbamic acid, N-[1,1'-biphenyl]-2-yl-, 1-[2-[[4-(hydroxymethyl)benzoyl]methylamino]ethyl]-4-piperidinyl ester](/CAS/20211123/GIF/1682660-39-4.gif) |
Carbamic acid, N-[1,1'-biphenyl]-2-yl-, 1-[2-[[4-(hydroxymethyl)benzoyl]methylamino]ethyl]-4-piperidinyl ester |
1682660-39-4 |
C29H33N3O4 |
![sodium 3-(4-((1H-imidazol-1-yl)methyl)phenyl)-3-hydroxypropanoate](/) |
sodium 3-(4-((1H-imidazol-1-yl)methyl)phenyl)-3-hydroxypropanoate |
|
|
![(4S,6R)-((4R,6S)-6-(2-(tert-butoxy)-2-oxoethyl)-2,2-dimethyl-1,3-dioxan-4-yl)methyl 6-(2-(tert-butoxy)-2-oxoethyl)-2,2-dimethyl-1,3-dioxane-4-carboxylate](/) |
(4S,6R)-((4R,6S)-6-(2-(tert-butoxy)-2-oxoethyl)-2,2-dimethyl-1,3-dioxan-4-yl)methyl 6-(2-(tert-butoxy)-2-oxoethyl)-2,2-dimethyl-1,3-dioxane-4-carboxylate |
|
|
![tert-butyl 2-(((Z)-(1-(2-aminothiazol-4-yl)-2-(((2S,3S)-2-methyl-4- oxoazetidin-3-yl)amino)-2-oxoethylidene)amino)oxy)-2-methyl propanoate](/) |
tert-butyl 2-(((Z)-(1-(2-aminothiazol-4-yl)-2-(((2S,3S)-2-methyl-4- oxoazetidin-3-yl)amino)-2-oxoethylidene)amino)oxy)-2-methyl propanoate |
|
|
![Atomoxetine Impurity 15](/CAS/20210111/GIF/881995-45-5.gif) |
Atomoxetine Impurity 15 |
881995-45-5 |
C19H23NO2 |
![Pitavastatin Impurity 13 (Pitavastatin 2,4,6-Triene Impurity)](/CAS/20210111/GIF/2086271-67-0.gif) |
Pitavastatin Impurity 13 (Pitavastatin 2,4,6-Triene Impurity) |
2086271-67-0 |
C25H20FNO2 |
![(2S,5R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-1,3-oxathiolane-2- carboxylic acid sodium](/) |
(2S,5R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-1,3-oxathiolane-2- carboxylic acid sodium |
|
|
![impurity 39](/) |
impurity 39 |
|
|
![(2R,3R,4R,5S)-6-((2,4-dibromo-6-((cyclohexyl(methyl)amino)methyl)phenyl)amino)hexane-1,2,3,4,5-pentaol](/) |
(2R,3R,4R,5S)-6-((2,4-dibromo-6-((cyclohexyl(methyl)amino)methyl)phenyl)amino)hexane-1,2,3,4,5-pentaol |
|
|
![Bosutinib Impurity 32](/) |
Bosutinib Impurity 32 |
|
|
![6,6'-Methylenebis[1,2,3,9-tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one](/CAS/20210111/GIF/1365727-09-8.gif) |
6,6'-Methylenebis[1,2,3,9-tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one |
1365727-09-8 |
C29H26N2O2 |
![Ampicillin Dimer Disodium Salt](/CAS/20211123/GIF/94730-51-5.gif) |
Ampicillin Dimer Disodium Salt |
94730-51-5 |
C32H39N6NaO8S2 |
![4-Thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, 6-(1-hydroxyethyl)-7-oxo-3-(tetrahydro-2-furanyl)-, [5R-[3(S*),5α,6α(R*)]]- (9CI)](/CAS/20211123/GIF/106560-13-8.gif) |
4-Thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, 6-(1-hydroxyethyl)-7-oxo-3-(tetrahydro-2-furanyl)-, [5R-[3(S*),5α,6α(R*)]]- (9CI) |
106560-13-8 |
C12H15NO5S |
![1-Naphthalenecarboxylic acid, 8-[[(3S)-1-azabicyclo[2.2.2]oct-3-ylamino]methyl]-5,6,7,8-tetrahydro-, (8S)-](/CAS/20210111/GIF/2407763-21-5.gif) |
1-Naphthalenecarboxylic acid, 8-[[(3S)-1-azabicyclo[2.2.2]oct-3-ylamino]methyl]-5,6,7,8-tetrahydro-, (8S)- |
2407763-21-5 |
C19H26N2O2 |
![Loratadine 2-Chloro IMpurity](/CAS/20200611/GIF/165739-64-0.gif) |
Loratadine 2-Chloro IMpurity |
165739-64-0 |
C22H22Cl2N2O2 |
![Metoprolol IMpurity F](/CAS/20150408/GIF/CB22674865.gif) |
Metoprolol IMpurity F |
|
C15H25NO3 |
![1-[2-(2-クロロベンジルオキシ)-2-(2,4-ジクロロフェニル)エチル]-1H-イミダゾール](/CAS/20180808/GIF/47363-37-1.gif) |
1-[2-(2-クロロベンジルオキシ)-2-(2,4-ジクロロフェニル)エチル]-1H-イミダゾール |
47363-37-1 |
C18H15Cl3N2O |
![Milrinone IMpurity 1](/) |
Milrinone IMpurity 1 |
|
|
![Nicardipine Related CoMpound 2](/CAS/20200611/GIF/64603-72-1.gif) |
Nicardipine Related CoMpound 2 |
64603-72-1 |
C16H14N2O6 |
![Saxagliptin IMpurity 1](/CAS/20210111/GIF/1564266-73-4.gif) |
Saxagliptin IMpurity 1 |
1564266-73-4 |
C6H10N2O |
![Sitagliptin DeaMino IMpurity 1](/CAS/20150408/GIF/1253056-18-6.gif) |
Sitagliptin DeaMino IMpurity 1 |
1253056-18-6 |
C16H12F6N4O |
![Sitagliptin Defuoro IMpurity 5](/CAS/20180808/GIF/486460-31-5.gif) |
Sitagliptin Defuoro IMpurity 5 |
486460-31-5 |
C16H16F5N5O |
![Dehydroxy BroMocelecoxib](/CAS/20200515/GIF/170570-75-9.gif) |
Dehydroxy BroMocelecoxib |
170570-75-9 |
C17H13BrF3N3O2S |
![Desethylene Norfloxacin Hydrochloride](/CAS/GIF/75001-77-3.gif) |
Desethylene Norfloxacin Hydrochloride |
75001-77-3 |
C14H16FN3O3 |
![p-(2,3-Epoxypropoxy)benzyl Alcohol](/CAS/20150408/GIF/4204-78-8.gif) |
p-(2,3-Epoxypropoxy)benzyl Alcohol |
4204-78-8 |
C10H12O3 |
![α-Etoposide](/CAS/20211123/GIF/100007-53-2.gif) |
α-Etoposide |
100007-53-2 |
C29H32O13 |
![N-Desmethyl-N-benzyl Sildenafil](/CAS/20140608/GIF/CB82700009.gif) |
N-Desmethyl-N-benzyl Sildenafil |
1446089-82-2 |
C28H34N6O4S |
![4-Hydroxy AtoMoxetine Oxalate](/CAS/20211123/GIF/457634-21-8.gif) |
4-Hydroxy AtoMoxetine Oxalate |
457634-21-8 |
C19H23NO6 |
![1-エチル-4-オキソ-6-クロロ-7-(1-ピペラジニル)-1,4-ジヒドロ-3-キノリンカルボン酸](/CAS/20150408/GIF/67681-84-9.gif) |
1-エチル-4-オキソ-6-クロロ-7-(1-ピペラジニル)-1,4-ジヒドロ-3-キノリンカルボン酸 |
67681-84-9 |
C16H18ClN3O3 |
![Desfluoro flurbiprofen axetil](/CAS/20210111/GIF/1685278-08-3.gif) |
Desfluoro flurbiprofen axetil |
1685278-08-3 |
C19H20O4 |
![Desloratadine IMpurity 6](/CAS/20180906/GIF/38092-90-9.gif) |
Desloratadine IMpurity 6 |
38092-90-9 |
C20H21ClN2 |
![ErtapeneM Ring Open IMpurity](/) |
ErtapeneM Ring Open IMpurity |
|
|
![LincoMycin iMpurity C](/) |
LincoMycin iMpurity C |
|
|
![Ivabradine Impurity S33172](/CAS/20200515/GIF/2247881-26-9.gif) |
Ivabradine Impurity S33172 |
2247881-26-9 |
C26H34N2O5 |
![Tenofovir Impurity 71](/) |
Tenofovir Impurity 71 |
|
|
![2-(chloromethyl)-3-methylpyridin-4-ol](/CAS/20200401/GIF/1805648-51-4.gif) |
2-(chloromethyl)-3-methylpyridin-4-ol |
1805648-51-4 |
C7H8ClNO |
![Mupirocin Calcium EP Impurity I](/CAS/20200401/GIF/CB85479591.gif) |
Mupirocin Calcium EP Impurity I |
|
C26H44CaO9 |
![Benzenepropanoic acid, α-hydroxy-β-[[(3E)-1-oxo-3-hexen-1-yl]amino]-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclod](/CAS/20210111/GIF/2243233-98-7.gif) |
Benzenepropanoic acid, α-hydroxy-β-[[(3E)-1-oxo-3-hexen-1-yl]amino]-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclod |
2243233-98-7 |
C46H55NO14 |
![D-erythro-Hexonic acid, 2,4-dideoxy-3,5-O-(1-methylethylidene)-6-S-(5-methyl-1,3,4-thiadiazol-2-yl)-6-thio-, 1,1-dimethylethyl ester](/CAS/20200611/GIF/1326303-05-2.gif) |
D-erythro-Hexonic acid, 2,4-dideoxy-3,5-O-(1-methylethylidene)-6-S-(5-methyl-1,3,4-thiadiazol-2-yl)-6-thio-, 1,1-dimethylethyl ester |
1326303-05-2 |
C16H26N2O4S2 |
![L-Leucine, N-[(2S)-2-amino-1-oxo-4-phenylbutyl]-](/CAS/20200401/GIF/290298-02-1.gif) |
L-Leucine, N-[(2S)-2-amino-1-oxo-4-phenylbutyl]- |
290298-02-1 |
C16H24N2O3 |
![5-Isobenzofurancarbonitrile, 1-[3-(dimethylamino)propyl]-1,3-dihydro-1-hydroxy-](/CAS/20200401/GIF/2102609-59-4.gif) |
5-Isobenzofurancarbonitrile, 1-[3-(dimethylamino)propyl]-1,3-dihydro-1-hydroxy- |
2102609-59-4 |
C14H18N2O2 |
![L-Milnacipran Carbamoyl-beta-D-Glucuronide](/CAS/20211123/GIF/1446438-98-7.gif) |
L-Milnacipran Carbamoyl-beta-D-Glucuronide |
1446438-98-7 |
C22H30N2O9 |
![1H-Imidazole-1-carboxylic acid, (1R)-2-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-1-[[[(2R)-3-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-2-[(1H-imidazol-1-ylcarbonyl)oxy]propyl][4-(3-oxo-4-morpholinyl)phenyl]amino]methyl]ethyl ester](/CAS/20200401/GIF/2097255-05-3.gif) |
1H-Imidazole-1-carboxylic acid, (1R)-2-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-1-[[[(2R)-3-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-2-[(1H-imidazol-1-ylcarbonyl)oxy]propyl][4-(3-oxo-4-morpholinyl)phenyl]amino]methyl]ethyl ester |
2097255-05-3 |
C40H34N8O10 |
![Elagolix Sodium impurity5](/) |
Elagolix Sodium impurity5 |
|
|